Biotech pharma

Nomic Bio

Website

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of prot

Founded 2017Origin source ↗Checked 2026-09-15

Overview

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool.

Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space.

Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic.

We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!

Company description As recorded 2026-11-08
LinkedIn GitHub
Biotech pharmaInfrastructureBusinessesEnterpriseServices

Founders & team

Previously nplex biosciences

Company history As recorded 2026-11-08
24team members reported
Source-reported As recorded 2026-09-15

Founded 2017 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthenriched profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedMontreal, QC, Canada
Pricing evidenceNo pricing page confirmed
Maturity: Launched · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The company website offers product access through a trial, free start, app download, purchase, or onboarding with existing-account login. Customer adoption is not established by this evidence.

Company website: home Checked 2026-09-23

Download the app note

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding yearrecent publishing observed
startup.observe Directory coverage · Sources & method